Evonik Venture Capital

Summary

Evonik Venture Capital appeared to be the VC, which was created in 2012. The main office of represented VC is situated in the Hanau. The fund was located in Europe if to be more exact in Germany. Evonik Venture Capital appeared to be a CVC structure as part of the corporation.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Evonik Venture Capital, startups are often financed by Horizons Ventures, Tau Ventures, SAM Private Equity. The meaningful sponsors for the fund in investment in the same round are Masdar Capital, BASF Venture Capital, VisVires New Protein. In the next rounds fund is usually obtained by Independence Equity, Huron River Ventures, Formation 8.

The fund was created by Lars Boehnisch. The overall number of key employees were 4.

Comparing to the other companies, this Evonik Venture Capital performs on 22 percentage points less the average number of lead investments. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. The increased amount of exits for fund were in 2018.

We can highlight the next thriving fund investment areas, such as Health Care, Advanced Materials. Among the various public portfolio startups of the fund, we may underline Modern Meadow, FRX Polymers, Biosynthetic Technologies Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.